Powering the Next Wave of Precision Genetic Medicines — Together
We believe in winning together and importantly, winning in our shared mission to help more patients in need.
Our goal is to maximize the potential of our SORT LNP delivery technology even beyond those rare diseases in our pipeline so that more patients may realize the full benefit of genetic medicines.
“We can enhance the potency of any genetic cargo by packaging it using our SORT LNP platform and delivering it directly to the organs and cells impacted by disease. This creates vast opportunities to address a wide range of medical needs not possible with current technologies.”
Shehnaaz Suliman, M.D., M.B.A., M.Phil.
Chief Executive Officer
Where to find ReCode this month:
May 23, 2024
Virtual Event
Virtual Piper Sandler Lung Day Post-ATS
Read More
May 17, 2024
San Diego, CA
American Thoracic Society: Respiratory Innovation Summit
Read More
May 14, 2024
Boston, MA
TIDES USA 2024
Read More
May 14, 2024
New York
Capital One Biotech – Life Sciences Disruptors
President & CSO David Lockhart attending
Read More
May 7, 2024
Baltimore, MD
ASGCT Annual Meeting
Read More
May 6, 2024
Virtual
Wells Fargo Virtual Private Biotech Symposium
CEO Shehnaaz Suliman attending.
Read More
Do you want to be on the frontier of a new generation of precision genetic medicines?
Contact us at [email protected]